VolitionRx Limited Revenue 2011–2025
VolitionRx Limited annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- VolitionRx Limited revenue for the quarter ending March 31, 2026 was 985076, a 299.81% increase year-over-year.
- VolitionRx Limited revenue for the twelve months ending March 31, 2026 was 2.3 M, a 87.68% increase year-over-year.
- VolitionRx Limited annual revenue for 2025 was 1.7 M, a 40.04% increase from 2024.
- VolitionRx Limited annual revenue for 2024 was 1.2 M, a 59.10% increase from 2023.
- VolitionRx Limited annual revenue for 2023 was 775302, a 153.04% increase from 2022.
- VolitionRx Limited annual revenue for 2022 was 306392.
VolitionRx Limited (VNRX) — Frequently Asked Questions
VolitionRx Limited (VNRX) is a publicly traded US company. It has a market capitalization of $147M. In fiscal 2025 it reported revenue of $2M and net income of -$23M. Explore VNRX's stock price, financial statements, earnings history, margins and key ratios below.
What is VolitionRx Limited's market cap?
VolitionRx Limited (VNRX) has a market capitalization of $147M.
What is the VNRX stock price?
VNRX trades at $1.38 (-0.72% on the day).
How much revenue does VolitionRx Limited make?
VolitionRx Limited reported revenue of $2M in fiscal 2025.
Is VNRX profitable?
In fiscal 2025, VolitionRx Limited reported net income of -$23M.